In this study, based on analysis of a large panel of clinical samples and melanoma cells from both male and female patients, we show that, irrespective of expression levels, genetic and pharmacological suppression of AR activity triggers melanoma cell senescence and limits tumorigenesis, eliciting a gene expression signature related to IFN and inflammatory cytokines and associated with better patients’ survival. Here, IFNA1 is linked to melanoma.